Alternative biomedical solutions to reduce bottlenecks in analytical testing of cannabis and psychedelic medicine

Sole partner for financing and start-up of cannabis analysis laboratories, design and construction of laboratories

There’s no doubt – done right, cannabis testing labs can quickly generate positive cash flow and deliver high returns to investors.

— Joseph Coffey, CEO Alternative Biomedical Solutions

LAS VEGAS, NEVADA, USA, Aug. 22, 2022 / — Cannabis Conference Booth #1011 – Alternative Biomedical Solutions “AltBio”, the nation’s leading provider of technical expertise and services to clinical laboratories and Diagnostics, will be exhibiting at Cannabis Conference 2022, August 23-25, at the Paris Las Vegas Hotel.

ABS has been in the lab business for over 30 years and brings a wealth of proven processes, scientific methods and intellectual property to cannabis and psychedelic drug testing lab projects. The management team attends the show to meet in person with independent and laboratory investment groups who wish to explore the cannabis testing laboratory market and who wish to explore a variety of independent equity financing options and/or of strategic partnership.

With over 3,000 industry professionals, the Cannabis Conference is the world’s most comprehensive conference where plant-related business professionals from across the United States and more than 30 countries come together to explore the most great challenges and opportunities of the legal cannabis and hemp industries.

“There’s no question – done right, cannabis testing labs can quickly generate positive cash flow and deliver high returns to investors,” said Joseph Coffey, CEO of AltBio. “We are certainly seeing an increase in inquiries for independent cannabis labs as more states decriminalize medical and recreational marijuana.”

“Building a cannabis testing lab is a multi-faceted project and a major undertaking. This requires specific knowledge and expertise in many areas: business planning, process and data management, chemical and biological testing, and a rapidly changing regulatory and statutory environment. »
“We are able to offer a start-to-finish solution with no franchise fees. We’re also OEM neutral — our flexible approach allows us to provide customers with exactly what they need. ABS engineers and scientists have developed processes that meet the most demanding cannabis regulatory requirements,” Coffey added.

“Certainly it’s early days we expect a similar trajectory for psychedelic testing – as more and more clinical research shows that they can be effective in treating conditions like depression, PTSD and some addictions – all psychedelics should be carefully tested.

“We are excited to attend the Cannabis Conference. With so many of our customers and contacts attending the show, we expect to have some very productive conversations.

About ABS
ABS’ mission is to advance human health and product safety by providing integrated technology and services to our customers. We serve toxicology, pain management, drug rehabilitation, criminal justice, forensics, environmental, cannabis, and other mature and emerging markets. ABS provides unbiased, neutral solutions for OEMs that enable innovation while providing world-class technical service. We also support our customers and markets with a state-of-the-art reference laboratory. ABS is a portfolio company of Center Lane Partners.

Jason Claybrook
Alternative biomedical solutions
+1 214-934-2001
write to us here
Visit us on social media: